Open AccessDe novo exon 18 G724S point mutation may be sensitive to Gefitinib
Author(s) -
Lee TaiHuang,
Yang ChihJen
Publication year - 2021
Publication title -
the kaohsiung journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.439
H-Index - 36
eISSN - 2410-8650
pISSN - 1607-551X
DOI - 10.1002/kjm2.12412
Subject(s) - gefitinib , osimertinib , t790m , medicine , adenocarcinoma , lung cancer , point mutation , exon , mutation , cancer research , epidermal growth factor receptor , adenocarcinoma of the lung , resistance mutation , oncology , pathology , cancer , erlotinib , polymerase chain reaction , gene , biology , genetics , reverse transcriptase
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom